FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the … - Yahoo Finance
TITUSVILLE, N.J., Feb. 10 /PRNewswire-FirstCall/ — Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today that the Food and Drug Administration (FDA) has asked for additional information regarding the company’s …